Opening R&D Address at World Antibiotic Resistance Congress
Filed with ASX · · 3 pages · English
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Appendix 4C and commentary
- Appointment of Independent Chair and Additional Director
- USA Patent Granted for Recces Antibiotics
- Recce Successfully Raises $1.8 million via Placement
- Change of Registry Address: Automic P/L - Sydney Office
Later from Recce Pharmaceuticals
- Key Family 2 Patent Granted in Europe for RECCE Antibiotics
- Response to ASX Appendix 4C Query
- FDA Positive Response for Recce Scaled Manufacture & Quality
- Appendix 4E - Preliminary Final Report
- Funding Update
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals